ATNM
Actinium Pharmaceuticals Inc
Description:
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplantation (BMT) or a type of cell therapy, and for other adoptive cell therapies. The company is headquartered in New York, New York.
Address:
100 PARK AVENUE, NEW YORK, NY, UNITED STATES, 10017
Fiscal year end:
December
Market capitalization:
$32 Million
Dividend per share:
$0.00
How much was you spent on shares:
$1,000
How much will you earn in
10 years:
-98%
How much will you get:
$19
Prices dates:
31-08-2016: $54.00 and 31-08-2026: $1.02